These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2156352)

  • 21. Inactivation of single-chain urokinase (pro-urokinase) by thrombin and thrombin-like enzymes: relevance of the findings to the interpretation of fibrin-binding experiments.
    Gurewich V; Pannell R
    Blood; 1987 Mar; 69(3):769-72. PubMed ID: 2949785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification and characterization of single-chain urokinase-type plasminogen activator from human cell cultures.
    Stump DC; Lijnen HR; Collen D
    J Biol Chem; 1986 Jan; 261(3):1274-8. PubMed ID: 3080423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a recombinant chimeric plasminogen activator composed of a fibrin fragment-D-dimer-specific humanized monoclonal antibody and a truncated single-chain urokinase.
    Vandamme AM; Dewerchin M; Lijnen HR; Bernar H; Bulens F; Nelles L; Collen D
    Eur J Biochem; 1992 Apr; 205(1):139-46. PubMed ID: 1313361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substrate specificity of tissue-type and urokinase-type plasminogen activators.
    Rijken DC; Groeneveld E
    Biochem Biophys Res Commun; 1991 Jan; 174(2):432-8. PubMed ID: 1899564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrin specific thrombolysis by two-chain urokinase-type plasminogen activator cleaved after arginine 156 by thrombin.
    Abercrombie DM; Buchinski B; Salvato KA; Vovis GF; Stump DC; Broeze RJ
    Thromb Haemost; 1990 Nov; 64(3):426-32. PubMed ID: 2128973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation and interrelationships of the multiple molecular tissue-type and urokinase-type plasminogen activator forms produced by cultured human umbilical vein endothelial cells.
    Booyse FM; Scheinbuks J; Lin PH; Traylor M; Bruce R
    J Biol Chem; 1988 Oct; 263(29):15129-38. PubMed ID: 3139666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of thrombolytic, fibrinolytic, and fibrinogenolytic properties of tissue plasminogen activator, streptokinase, single-chain urokinase, high molecular weight and low molecular weight urokinase in human plasma in vitro.
    Samama M; Nguyen G; Desnoyers P; Lourenco DM; Fretault J; Horellou MH; Conard J; Szwarcer E; Verdy E; Vahanian A
    Fundam Clin Pharmacol; 1988; 2(6):509-23. PubMed ID: 3149257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bovine erythrocyte haemolysates enhance plasminogen activation by tissue-type plasminogen activator.
    Yamada M; Horiuchi T; Oribe T; Yamamoto S; Sugie I; Gentry PA
    Vet Res Commun; 1997 Feb; 21(2):75-84. PubMed ID: 9061881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of plasmin catalyzed conversion of single-chain to two-chain urokinase-type plasminogen activator by sulfated polysaccharides.
    Rydzewski A; Takada Y; Takada A
    Thromb Haemost; 1989 Sep; 62(2):752-5. PubMed ID: 2479114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of heparan sulfate analogue or other sulfated polysaccharides on the activation of plasminogen by t-PA or u-PA.
    Takada Y; Urano T; Takada A
    Thromb Res; 1994 Mar; 73(5):301-11. PubMed ID: 8016815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conjugation to antifibrin Fab' enhances fibrinolytic potency of single-chain urokinase plasminogen activator.
    Bode C; Runge MS; Schönermark S; Eberle T; Newell JB; Kübler W; Haber E
    Circulation; 1990 Jun; 81(6):1974-80. PubMed ID: 2111744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160.
    Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
    Eur J Biochem; 1988 Nov; 177(3):575-82. PubMed ID: 2973984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a nonglycosylated single chain urinary plasminogen activator secreted from yeast.
    Melnick LM; Turner BG; Puma P; Price-Tillotson B; Salvato KA; Dumais DR; Moir DT; Broeze RJ; Avgerinos GC
    J Biol Chem; 1990 Jan; 265(2):801-7. PubMed ID: 2104831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Single-chain urokinase-type plasminogen activator (scu-PA) purification by immuno-affinity chromatography].
    Gao LH; Hu XW; Wu QF; Xiao CZ; Xu ZP; Zhang ZG
    Sheng Wu Gong Cheng Xue Bao; 2002 May; 18(3):356-9. PubMed ID: 12192874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the in vitro fibrinolytic activities of low and high molecular weight single-chain urokinase-type plasminogen activator.
    de Munk GA; Groeneveld E; Rijken DC
    Thromb Haemost; 1993 Sep; 70(3):481-5. PubMed ID: 8259553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasminogen activator in psoriatic scales is of the tissue-type PA as identified by monoclonal antibodies.
    Grøndahl-Hansen J; Nielsen LS; Kristensen P; Grøndahl-Hansen V; Andreasen PA; Danø K
    Br J Dermatol; 1985 Sep; 113(3):257-63. PubMed ID: 3933538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen.
    Andrade-Gordon P; Strickland S
    Biochemistry; 1986 Jul; 25(14):4033-40. PubMed ID: 2943315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of monoclonal antibodies on tissue-type plasminogen activator (t-PA) binding to lysine, fibrin and heparin and on fibrin-mediated enhancement of one-chain t-PA amidolytic activity.
    Fischer B; Zacharias U; Will H
    Biol Chem Hoppe Seyler; 1991 Apr; 372(4):263-71. PubMed ID: 1905550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nerve growth factor-gamma activates soluble and receptor-bound single chain urokinase-type plasminogen activator.
    Wolf BB; Vasudevan J; Henkin J; Gonias SL
    J Biol Chem; 1993 Aug; 268(22):16327-31. PubMed ID: 8393859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation of plasminogen activator inhibitor-2 (PAI-2) from human placenta. Evidence for vitronectin/PAI-2 complexes in human placenta extract.
    Radtke KP; Wenz KH; Heimburger N
    Biol Chem Hoppe Seyler; 1990 Dec; 371(12):1119-27. PubMed ID: 1708670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.